The expression of PD-L1 in patients with castrate prostate cancer treated by enzalutamide

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorJirásek Tomášcs
dc.contributor.authorHavlíčková Ivanacs
dc.contributor.authorČurčíková Radmilacs
dc.contributor.authorŠámal Vladimírcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2020-06-08T09:39:01Z
dc.date.available21-58-2019en
dc.date.available2020-06-08T09:39:01Z
dc.date.issued2018cs
dc.date.updated29-03-2019en
dc.format.extent7cs
dc.identifier.issn1107-0625cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155571
dc.language.isoengcs
dc.publisher.cityAthénycs
dc.relation.ispartofJBuonen
dc.relation.ispartofseries1cs
dc.subjectcastration-resistantcs
dc.subjectenzalutamidecs
dc.subjectmetastaticprostate cancercs
dc.subjectPD-L1cs
dc.titleThe expression of PD-L1 in patients with castrate prostate cancer treated by enzalutamidecs
local.citation.epage1796-1802cs
local.citation.spage1796-1802cs
local.identifier.publikace6175
local.relation.issue6cs
Files
Collections